Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort

The full spectrum of the clinical phenotype of facioscapulohumeral muscular dystrophy (FSHD), beyond skeletal muscle weakness, remains poorly characterized. In this study, we describe systemic manifestations and symptom burden in a large series of FSHD patients.

[1]  C. Banerji,et al.  Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7 , 2021, EMBO molecular medicine.

[2]  V. Somers,et al.  Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD) , 2021, Frontiers in Neurology.

[3]  C. Morse,et al.  Psychological parameters impact health-related quality of life in mental and physical domains in adults with muscular dystrophy , 2021, Neuromuscular Disorders.

[4]  Tai-Heng Chen,et al.  Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review , 2020, International journal of molecular sciences.

[5]  R. Tupler,et al.  Cochlear Dysfunction Is a Frequent Feature of Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) , 2020, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[6]  Kathryn R. Wagner.  Facioscapulohumeral Muscular Dystrophies. , 2019, Continuum.

[7]  W. Randerath,et al.  Respiratory muscle weakness in facioscapulohumeral muscular dystrophy , 2019, Muscle & nerve.

[8]  M. Mcdermott,et al.  Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD) , 2019, Neurology.

[9]  P. Kellman,et al.  Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction – assessment by cardiovascular magnetic resonance , 2019, Journal of Cardiovascular Magnetic Resonance.

[10]  A. Heidbreder,et al.  Sleep-related breathing disorders in facioscapulohumeral dystrophy , 2019, Sleep and Breathing.

[11]  J. Statland,et al.  Effects of weakness of orofacial muscles on swallowing and communication in FSHD , 2019, Neurology.

[12]  J. Statland,et al.  Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy , 2019, Neurology.

[13]  T. Theelen,et al.  Ophthalmological findings in facioscapulohumeral dystrophy , 2019, Brain communications.

[14]  G. Bassez,et al.  Assessment of diaphragm motion using ultrasonography in a patient with facio-scapulo-humeral dystrophy , 2019, Medicine.

[15]  R. Tawil,et al.  Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments , 2018, Neurotherapeutics.

[16]  A. Cnaan,et al.  A multinational study on motor function in early-onset FSHD , 2018, Neurology.

[17]  H. Lochmüller,et al.  Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy , 2017, Muscle & nerve.

[18]  F. Chapon,et al.  Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular Dystrophy , 2017, Journal of clinical neuromuscular disease.

[19]  A. Mayhew,et al.  Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy , 2017, Journal of Neurology.

[20]  S. Pandya,et al.  Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy , 2015, Neurology.

[21]  N. van Alfen,et al.  Facioscapulohumeral muscular dystrophy and respiratory failure; what about the diaphragm? , 2014, Respiratory medicine case reports.

[22]  R. Tawil,et al.  Restrictive lung involvement in facioscapulohumeral muscular dystrophy , 2014, Muscle & nerve.

[23]  J. Timmermans,et al.  High prevalence of incomplete right bundle branch block in facioscapulohumeral muscular dystrophy without cardiac symptoms. , 2014, Functional neurology.

[24]  J. Miró,et al.  Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain , 2014, Muscle & nerve.

[25]  J. Statland,et al.  Risk of functional impairment in Facioscapulohumeral muscular dystrophy , 2014, Muscle & nerve.

[26]  K. Mathews,et al.  Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy , 2013, Neurology.

[27]  J. Statland,et al.  Coats syndrome in facioscapulohumeral dystrophy type 1 , 2013, Neurology.

[28]  A. Pedotti,et al.  Respiratory pattern in an adult population of dystrophic patients , 2011, Journal of the Neurological Sciences.

[29]  L. Padua,et al.  Quality of life and pain in patients with facioscapulohumeral muscular dystrophy , 2009, Muscle & nerve.

[30]  J. Stübgen,et al.  Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy , 2009, Muscle & nerve.

[31]  A. López de Munain,et al.  Cognitive function in facioscapulohumeral dystrophy correlates with the molecular defect , 2009, Genes, brain, and behavior.

[32]  G. Siciliano,et al.  Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions , 2008, European journal of neurology.

[33]  R. Abresch,et al.  Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. , 2008, Archives of physical medicine and rehabilitation.

[34]  J. Stübgen.  Facioscapulohumeral Muscular Dystrophy: A Radiologic and Manometric Study of the Pharynx and Esophagus , 2008, Dysphagia.

[35]  C. Angelini,et al.  Facioscapulohumeral Muscular Dystrophy: A Multicenter Study on Hearing Function , 2007, Audiology and Neurotology.

[36]  M. Zwarts,et al.  Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I , 2007, Acta neurologica Scandinavica.

[37]  D. Vassilopoulos,et al.  Cochlear Function in Facioscapulohumeral Muscular Dystrophy , 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[38]  C. Angelini,et al.  Facioscapulohumeral Muscular Dystrophy and Occurrence of Heart Arrhythmia , 2006, European Neurology.

[39]  B. D. de Swart,et al.  Dysphagia in facioscapulohumeral muscular dystrophy , 2006, Neurology.

[40]  G. Siciliano,et al.  Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy , 2005, Neuromuscular Disorders.

[41]  G. V. Ommen,et al.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere , 2002, Nature Genetics.

[42]  Mark T Rogers,et al.  Absence of hearing impairment in adult onset facioscapulohumeral muscular dystrophy , 2002, Neuromuscular Disorders.

[43]  J. J. Grote,et al.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy , 1995, Muscle & nerve. Supplement.

[44]  C. Wijmenga,et al.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy , 1992, Nature genetics.

[45]  W. Stevenson,et al.  Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. , 1990, Journal of the American College of Cardiology.

[46]  P Halonen,et al.  [Facioscapulohumeral muscular dystrophy]. , 1990, Duodecim; laaketieteellinen aikakauskirja.